Protein Phosphatases as Therapeutic Targets for Cancer and Alzheimer's Disease

Strategic Insights -

Researchers at the University of Pittsburgh have identified protein phosphatases, specifically dual-specificity phosphatases (DSPases), as potential therapeutic targets for the treatment of cancer and Alzheimer's disease. The study, published in the Annual Review of Pharmacology and Toxicology, highlights the critical roles of DSPases in multiple signaling pathways and their deregulation in various diseases. The researchers aim to explore the feasibility of using DSPases as new molecular therapeutic targets for human disease.

Key Takeaways:

  • Dual-specificity phosphatases (DSPases) are critical in multiple signaling pathways and are deregulated in cancer and Alzheimer's disease.
  • DSPases are potential therapeutic targets for the treatment of human disease, offering a new molecular target for drug discovery efforts.
  • The study emphasizes the importance of understanding the pathophysiological roles of DSPases and assessing their suitability for therapeutic intervention.
  • Alexander P. Ducruet and colleagues at the University of Pittsburgh led the research, publishing their study in the Annual Review of Pharmacology and Toxicology in 2005.
  • The study contributes to the growing understanding of DSPases in cancer and Alzheimer's disease, with implications for pharmaceutical and drug development.

Statistics:

  • Data from the study are presented in the journal Annual Review of Pharmacology and Toxicology, with page numbers 725-750.
  • The study targets dual-specificity phosphatases (DSPases) as key enzyme types involved in disease regulation.
  • Researchers aim to explore the therapeutic potential of DSPases for human disease, focusing on cancer and Alzheimer's disease.
  • The study highlights the critical role of DSPases in multiple signaling pathways, underscoring their potential as therapeutic targets.

Sources:

  • Annual Review of Pharmacology and Toxicology, (2005): Dual specificity protein phosphatases: Therapeutic targets for cancer and Alzheimer's disease, Arithmetic page numbers 725-750
  • Health & Medicine Week, online article, Copyright 2005, Health & Medicine Week via NewsRx.com